Use of monoclonal antibodies to assess expression of anaphylatoxin receptors in tubular epithelial cells of human, murine and rat kidneys

Immunobiology

Volumn 212, Issue 2, 2007, Pages 129-139

  Kiafard, Ziba ^a   Tschernig, Thomas ^b   Schweyer, Stefan ^a   Bley, Annette ^a   Neumann, Detlef ^b   Zwirner, Jörg ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Complement; Immunohistochemistry; Kidney; Monoclonal antibody; Renal tubular epithelial cells

Indexed keywords

ANTIGEN; COMPLEMENT COMPONENT C3A RECEPTOR; COMPLEMENT COMPONENT C5A RECEPTOR; COMPLEMENT RECEPTOR; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL TISSUE; ANTIGEN DETECTION; ARTICLE; BAGG ALBINO MOUSE; CELL INFILTRATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; HUMAN VERSUS ANIMAL COMPARISON; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; KIDNEY EPITHELIUM; LEUKOCYTE; MACROPHAGE; MALE; MOUSE; MURPHY ROTHS LARGE LYMPHOPROLIFERATIVE MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; SEQUENCE ANALYSIS;

EID: 33847307119     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imbio.2006.11.003     Document Type: Article

References (35)

1. Abe K., Miyazaki M., Koji T., Furusu A., Nakamura-Kurashige T., Nishino T., Ozono Y., Harada T., Sakai H., and Kohno S. Enhanced expression of complement C5a receptor mRNA in human diseased kidney assessed by in situ hybridization. Kidney Int. 60 (2001) 137-146
2. Ames R.S., Li Y., Sarau H.M., Nuthulaganti P., Foley J.J., Ellis C., Zeng Z., Su K., Jurewicz A.J., Hertzberg R.P., Bergsma D.J., and Kumar C. Molecular cloning and characterization of the human anaphylatoxin C3a receptor. J. Biol. Chem. 271 (1996) 20231-20234
3. Bao L., Osawe I., Haas M., and Quigg R.J. Signaling through up-regulated C3a receptor is key to the development of experimental lupus nephritis. J. Immunol. 175 (2005) 1947-1955
4. Bao L., Osawe I., Puri T., Lambris J.D., Haas M., and Quigg R.J. C5a promotes development of experimental lupus nephritis which can be blocked with a specific receptor antagonist. Eur. J. Immunol. 35 (2005) 2496-2506
5. Braun M.C., Reins R.Y., Li T.B., Hollmann T.J., Dutta R., Rick W.A., Teng B.B., and Ke B. Renal expression of the C3a receptor and functional responses of primary human proximal tubular epithelial cells. J. Immunol. 173 (2004) 4190-4196
6. de Vries B., Kohl J., Leclercq W.K., Wolfs T.G., van Bijnen A.A., Heeringa P., and Buurman W.A. Complement factor C5a mediates renal ischemia-reperfusion injury independent from neutrophils. J. Immunol. 170 (2003) 3883-3889
7. Drouin S.M., Kildsgaard J., Haviland J., Zabner J., Jia H.P., McCray P.B., Tack B.F., and Wetsel R.A. Expression of the complement anaphylatoxin C3a and C5a receptors on bronchial epithelial and smooth muscle cells in models of sepsis and asthma. J. Immunol. 166 (2001) 2025-2032
8. Farzan M., Schnitzler C.E., Vasilieva N., Leung D., Kuhn J., Gerard C., Gerard N.P., and Choe H. Sulfated tyrosines contribute to the formation of the C5a docking site of the human C5a anaphylatoxin receptor. J. Exp. Med. 193 (2001) 1059-1066
9. Fayyazi A., Scheel O., Werfel T., Schweyer S., Oppermann M., Gotze O., Radzun H.J., and Zwirner J. The C5a receptor is expressed in normal renal proximal tubular but not in normal pulmonary or hepatic epithelial cells. Immunology 99 (2000) 38-45
10. Freeman G.J., Cardoso A.A., Boussiotis V.A., Anumanthan A., Groves R.W., Kupper T.S., Clark E.A., and Nadler L.M. The BB1 monoclonal antibody recognizes both cell surface CD74 (MHC class II-associated invariant chain) as well as B7-1 (CD80), resolving the question regarding a third CD28/CTLA-4 counterreceptor. J. Immunol. 161 (1998) 2708-2715
11. Fregonese L., Swan F.J., van Schadewijk A., Dolhnikoff M., Santos M.A., Daha M.R., Stolk J., Tschernig T., Sterk P.J., Hiemstra P.S., Rabe K.F., and Mauad T. Expression of the anaphylatoxin receptors C3aR and C5aR is increased in fatal asthma. J. Allergy Clin. Immunol. 115 (2005) 1148-1154
12. Fukuoka Y., Ember J.A., and Hugli T.E. Cloning and characterization of rat C3a receptor: differential expression of rat C3a and C5a receptors by LPS stimulation. Biochem. Biophys. Res. Commun. 242 (1998) 663-668
13. Gao J., Choe H., Bota D., Wright P.L., Gerard C., and Gerard N.P. Sulfation of tyrosine 174 in the human C3a receptor is essential for binding of C3a anaphylatoxin. J. Biol. Chem. 278 (2003) 37902-37908
14. Gerard C., and Gerard N.P. C5a anaphylatoxin and its seven transmembrane-segment receptor. Annu. Rev. Immunol. 12 (1994) 775-808
15. Kiafard, Z., Zwirner, J., C3a receptor expression in the mouse as assessed by monoclonal antibodies. Manuscript in preparation.
16. Oppermann M., Raedt U., Hebell T., Schmidt B., Zimmermann B., and Gotze O. Probing the human receptor for C5a anaphylatoxin with site-directed antibodies. Identification of a potential ligand binding site on the NH2-terminal domain. J. Immunol. 151 (1993) 3785-3794
17. Peake P.W., O'Grady S., Pussell B.A., and Charlesworth J. C3a is made by proximal tubular HK-2 cells and activates them via the C3a receptor. Kidney Int. 56 (1999) 1729-1736
18. Potgens A.J., Schmitz U., Kaufmann P., and Frank H.G. Monoclonal antibody CD133-2 (AC141) against hematopoietic stem cell antigen CD133 shows crossreactivity with cytokeratin 18. J. Histochem. Cytochem. 50 (2002) 1131-1134
19. Riedemann N.C., Guo R.F., Neff T.A., Laudes I.J., Keller K.A., Sarma V.J., Markiewski M.M., Mastellos D., Strey C.W., Pierson C.L., Lambris J.D., Zetoune F.S., and Ward P.A. Increased C5a receptor expression in sepsis. J. Clin. Invest. 110 (2002) 101-108
20. Rothermel E., Zwirner J., Vogt T., Rabini S., and Gotze O. Molecular cloning and expression of the functional rat C5a receptor. Mol. Immunol. 34 (1997) 877-886
21. Rothermel E., Gotze O., Zahn S., and Schlaf G. Analysis of the tissue distribution of the rat C5a receptor and inhibition of C5a-mediated effects through the use of two MoAbs. Scand. J. Immunol. 52 (2000) 401-410
22. Schakel K., Kannagi R., Kniep B., Goto Y., Mitsuoka C., Zwirner J., Soruri A., von Kietzell M., and Rieber E. 6-Sulfo LacNAc, a novel carbohydrate modification of PSGL-1, defines an inflammatory type of human dendritic cells. Immunity 17 (2002) 289-301
23. Sohns, B., 2000. Untersuchungen zur Expression des humanen C3a-Rezeptors. Ph.D. Thesis, University of Hannover, Hannover, Germany.
24. Sohns B., Westermann J., Frank R., Grove M., Kohl J., Klos A., and Bautsch W. A murine monoclonal antibody against the human C3a-receptor: high expression on non-myeloid cells of human placenta [Abstract Q5]. Immunobiology 199 3-5 (1998) 630
25. Soruri A., Kiafard Z., Dettmer C., Riggert J., Kohl J., and Zwirner J. IL-4 down-regulates anaphylatoxin receptors in monocytes and dendritic cells and impairs anaphylatoxin-induced migration in vivo. J. Immunol. 170 (2003) 3306-3314
26. Soruri A., Kim S., Kiafard Z., and Zwirner J. Characterization of C5aR expression on murine myeloid and lymphoid cells by the use of a novel monoclonal antibody. Immunol. Lett. 88 (2003) 47-52
27. Thangam E.B., Venkatesha R.T., Zaidi A.K., Jordan-Sciutto K.L., Goncharov D.A., Krymskaya V.P., Amrani Y., Panettieri Jr. R.A., and Ali H. Airway smooth muscle cells enhance C3a-induced mast cell degranulation following cell-cell contact. FASEB J. 19 (2005) 798-800
28. Tornetta M.A., Foley J.J., Sarau H.M., and Ames R.S. The mouse anaphylatoxin C3a receptor: molecular cloning, genomic organization, and functional expression. J. Immunol. 158 (1997) 5277-5282
29. Utsunomiya K., Watanabe J., Takamori Y., Kataoka Y., Kurokawa K., and Yamada H. Crossreaction with an anti-Bax antibody reveals novel multi-endocrine cellular antigen. J. Histochem. Cytochem. 52 (2004) 805-812
30. Walport M.J. Advances in immunology: complement. N. Engl. J. Med. 344 (2001) 1058-1066
31. Welch T.R., Frenzke M., Witte D., and Davis A.E. C5a is important in the tubulointerstitial component of experimental immune complex glomerulonephritis. Clin. Exp. Immunol. 130 (2002) 43-48
32. Wenderfer S.E., Ke B., Hollmann T.J., Wetsel R.A., Lan H.Y., and Braun M.C. C5a receptor deficiency attenuates T cell function and renal disease in MRLlpr mice. J. Am. Soc. Nephrol. 16 12 (2005) 3572-3582
33. Werfel T., Zwirner J., Oppermann M., Sieber A., Begemann G., Drommer W., Kapp A., and Gotze O. CD88 antibodies specifically bind to C5aR on dermal CD117+ and CD14+ cells and react with a desmosomal antigen in human skin. J. Immunol. 157 (1996) 1729-1735
34. Zwirner J., Fayyazi A., and Gotze O. Expression of the anaphylatoxin C5a receptor in non-myeloid cells. Mol. Immunol. 36 (1999) 877-884
35. Zwirner J., Gotze O., Begemann G., Kapp A., Kirchhoff K., and Werfel T. Evaluation of C3a receptor expression on human leucocytes by the use of novel monoclonal antibodies. Immunology 97 (1999) 166-172